Paradromics key facts
as of Oct 2026- Developer of a brain-computer interface technology designed to record and interpret brain activity for medical use.
- Paradromics is valued at approximately $300.1M as of Oct 2026, set at its later-stage round, Nov 2023; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $127.4M across 4 recorded rounds; the latest was Later Stage VC ($50.1M) in Mar 2023.
- Notable investors include FJ Labs, Mana Ventures, Gaingels, Capital Factory, Joyance Partners — 51 tracked in total.
- 6 investment vehicles were formed to buy Paradromics shares in the last 12 months, reporting $12.9M sold to 141 investors, per SEC Form D filings.
- Paradromics has filed 7 Form Ds with the SEC since 2019, most recently Nov 2023 ($50.1M sold to 53 investors).
- Status: Privately Held (backing).
Valued at $300.1M at its later-stage round, Nov 2023. Nothing has traded since.
- ·The complete investor list: 51 names
- ·Watch Paradromics: the Monday email on marks, rounds and moves
Paradromics funding rounds
4 roundsVehicles formed to buy Paradromics shares
secondary demand · SEC Form D filingsIn the last 12 months, 6 investment vehicles were formed to buy Paradromics shares, reporting $12.9M sold to 141 investors across 6 sponsors. Most recent filing Jun 2026.
Membership and data by Private Market View
Who backs Paradromics
51+Membership and data by Private Market View
Paradromics valuation
Paradromics was valued at $300 million at its later-stage round in Nov 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Paradromics raised?
Paradromics has raised $127 million across 4 recorded rounds since 2019. The largest was an $8.9 million early-stage round in Feb 2022; the most recent was a $50.1 million later-stage round in Mar 2023.
Paradromics has filed 7 Form Ds with the SEC since 2019, most recently in Nov 2023 ($50.1 million sold to 53 investors).
Institutional holders and vehicles
In the last 12 months, 6 investment vehicles were formed to buy Paradromics shares, reporting $12.9 million sold to 141 investors across 6 sponsors, per SEC Form D filings (most recent Jun 2026).
Paradromics investors
51 investors are on record for Paradromics, including FJ Labs, Mana Ventures, Gaingels and Capital Factory. By type, the record holds 15 venture capital firms, 2 hedge funds and 2 asset managers. The later-stage round in Mar 2023 drew 53 investors.
About Paradromics
Developer of a brain-computer interface technology designed to record and interpret brain activity for medical use. The company's technology offers implantable neural interfaces, data processing software, and machine learning models to capture single-neuron signals, process large volumes of brain activity data, and convert those signals into usable outputs for medical applications, enabling patients with neurological conditions and clinical research teams to translate brain signals into actionable data for communication and therapeutic applications.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2015
- Employees
- 98
- Website
- paradromics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.